Veryan Medical

3D stent for peripheral vascular disease

placeHorsham, England, United Kingdom calendar_todayFounded 2003 groups35 employees language veryanmed.com

Registered entities

Innovation

28 patent families (17 granted) — focus: Human necessities, Mechanical engineering; filing pace slowing. Cited 1,426 times.

YearFilings
20131
20147
20156
20167
20175
20183
20194
20203
20213
20221
20232
20251

Social engagement

Social engagement: 14.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Imperial Innovations, Oxford Capital, Seroba Life Sciences, Nesta Impact Investments.

Investor typeCountShare
Venture capital240%
Private equity120%
Accelerator & incubator120%
Other / undisclosed120%

Recent activity

21 May 2026
Event
NCVH 2026
12 May 2026
Product launch
RevolutionTM Peripheral Atherectomy System
6 May 2026
Event
New Cardiovascular Horizons (NCVH) Annual Conference
Coming soon